Related Experiment Video
Updated: Jul 11, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Advances, opportunities and challenges in developing therapeutic cancer vaccines
Zhihui Duan1, Dandan Yang1, Ping Yuan1
1Laboratory of Structural Immunology, Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Abstract:
Therapeutic cancer vaccines have shown promising efficacy in helping immunotherapy for cancer patients, but the systematic characterization of the clinical application and the method for improving efficacy is lacking. Here, we mainly summarize the classification of therapeutic cancer vaccines, including protein vaccines, nucleic acid vaccines, cellular vaccines and anti-idiotypic antibody vaccines, and subdivide the above vaccines according to different types and delivery forms. Additionally, we outline the clinical efficacy and safety of vaccines, as well as the combination strategies of therapeutic cancer vaccines with other therapies. This review will provide a detailed overview and rationale for the future clinical application and development of therapeutic cancer vaccines.
Insights
Therapeutic cancer vaccines show promise in immunotherapy, but systematic characterization is needed. This review details vaccine types, efficacy, safety, and combination strategies for future development.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Therapeutic cancer vaccines show promise for immunotherapy.
- Systematic characterization of their clinical application and efficacy improvement is lacking.
Purpose of the Study:
- To systematically review therapeutic cancer vaccines.
- To summarize their classification, clinical efficacy, safety, and combination strategies.
Main Methods:
- Literature review and synthesis.
- Classification of vaccines by type and delivery form.
- Outline of clinical data and combination strategies.
Main Results:
- Categorized therapeutic cancer vaccines into protein, nucleic acid, cellular, and anti-idiotypic antibody types.
- Detailed vaccine subtypes and delivery forms.
- Summarized clinical efficacy, safety profiles, and combination therapies.
Conclusions:
- Therapeutic cancer vaccines are a developing field with diverse approaches.
- Understanding their efficacy, safety, and combinations is crucial for future clinical applications.
- This review provides a rationale for advancing therapeutic cancer vaccine development.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...